Björn Zethelius

17.1k total citations · 2 hit papers
147 papers, 9.3k citations indexed

About

Björn Zethelius is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Björn Zethelius has authored 147 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Endocrinology, Diabetes and Metabolism, 42 papers in Cardiology and Cardiovascular Medicine and 24 papers in Molecular Biology. Recurrent topics in Björn Zethelius's work include Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers), Diabetes Treatment and Management (32 papers) and Diabetes Management and Research (24 papers). Björn Zethelius is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers), Diabetes Treatment and Management (32 papers) and Diabetes Management and Research (24 papers). Björn Zethelius collaborates with scholars based in Sweden, United Kingdom and United States. Björn Zethelius's co-authors include Lars Lind, Johan Sundström, Hans Lithell, Björn Eliasson, Soffia Guðbjörnsdóttir, Johan Ärnlöv, Lars Berglund, Erik Ingelsson, Christian Berne and Per Venge and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Björn Zethelius

142 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes

2018 898 citations Aidin Rawshani, Araz Rawshani et al. New England Journal of Medicine profile →
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes

2008 675 citations Björn Zethelius, Lars Berglund et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Björn Zethelius Sweden	50	3.6k	3.2k	1.7k	1.6k	1.5k	147	9.3k
Bernard M.Y. Cheung Hong Kong	49	2.6k 0.7×	2.9k 0.9×	1.5k 0.9×	1.8k 1.2×	1.4k 0.9×	254	9.5k
David C. Robbins United States	47	3.4k 1.0×	2.5k 0.8×	1.6k 1.0×	1.0k 0.7×	1.7k 1.2×	118	8.2k
Alexandra Kautzky‐Willer Austria	52	3.6k 1.0×	1.8k 0.6×	1.8k 1.1×	1.7k 1.1×	2.4k 1.6×	461	11.3k
Francesco Perticone Italy	52	2.9k 0.8×	4.5k 1.4×	1.9k 1.1×	2.0k 1.3×	1.3k 0.9×	269	10.4k
George Jerums Australia	66	4.6k 1.3×	2.7k 0.9×	1.6k 1.0×	2.1k 1.4×	1.3k 0.9×	285	13.4k
Joshua I. Barzilay United States	49	3.9k 1.1×	2.6k 0.8×	1.3k 0.7×	1.3k 0.8×	1.5k 1.0×	160	8.1k
Kristian B. Filion Canada	50	2.9k 0.8×	4.2k 1.3×	1.8k 1.0×	1.3k 0.9×	2.0k 1.3×	283	11.8k
Nicolas Rodondi Switzerland	54	3.5k 1.0×	3.2k 1.0×	1.2k 0.7×	896 0.6×	1.7k 1.1×	397	10.7k
Aruna D. Pradhan United States	42	2.9k 0.8×	2.4k 0.8×	1.6k 1.0×	1.6k 1.1×	2.5k 1.7×	88	10.0k
Peter Gæde Denmark	24	5.3k 1.5×	2.3k 0.7×	1.1k 0.7×	1.2k 0.8×	1.4k 0.9×	92	8.3k

Countries citing papers authored by Björn Zethelius

Since Specialization

Citations

This map shows the geographic impact of Björn Zethelius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Zethelius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Zethelius more than expected).

Fields of papers citing papers by Björn Zethelius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Zethelius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Zethelius. The network helps show where Björn Zethelius may publish in the future.

Co-authorship network of co-authors of Björn Zethelius

This figure shows the co-authorship network connecting the top 25 collaborators of Björn Zethelius. A scholar is included among the top collaborators of Björn Zethelius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Zethelius. Björn Zethelius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zethelius, Björn, et al.. (2024). Pulmonary embolism after SARS-CoV-2 vaccination. Vaccine X. 21. 100571–100571.

Gedeborg, Rolf, Lennart Holm, Nils Feltelius, et al.. (2023). Validation of myocarditis diagnoses in the Swedish patient register for analyses of potential adverse reactions to COVID-19 vaccines. Upsala Journal of Medical Sciences. 128. 6 indexed citations

Ljung, Rickard, et al.. (2022). Comparison of years of life lost to 1,565 suicides versus 10,650 COVID-19 deaths in 2020 in Sweden: four times more years of life lost per suicide than per COVID-19 death. Upsala Journal of Medical Sciences. 127. 2 indexed citations

Zethelius, Björn, et al.. (2019). The impact of muscle function, muscle mass and sarcopenia on independent ageing in very old Swedish men. BMC Geriatrics. 19(1). 153–153. 37 indexed citations

Crawley, Danielle, Hans Garmo, Sarah Rudman, et al.. (2018). Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study. BMJ Open. 8(3). e020787–e020787. 7 indexed citations

Rawshani, Aidin, Araz Rawshani, Stefan Franzén, et al.. (2018). Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine. 379(7). 633–644. 898 indexed citations breakdown →

Rowley, M., Hans Garmo, Mieke Van Hemelrijck, et al.. (2017). A latent class model for competing risks. Statistics in Medicine. 36(13). 2100–2119. 10 indexed citations

Butwicka, Agnieszka, Louise Frisén, Catarina Almqvist, Björn Zethelius, & Paul Lichtenstein. (2015). Risks of Psychiatric Disorders and Suicide Attempts in Children and Adolescents With Type 1 Diabetes: A Population-Based Cohort Study. Diabetes Care. 38(3). 453–459. 139 indexed citations

Song, Xin, Ádám G. Tabák, Björn Zethelius, et al.. (2014). Obesity attenuates gender differences in cardiovascular mortality. Cardiovascular Diabetology. 13(1). 144–144. 39 indexed citations

10.

Wallentin, Lars, Björn Zethelius, Lars Berglund, et al.. (2013). GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men. PLoS ONE. 8(12). e78797–e78797. 111 indexed citations

11.

Ekström, Nils, Mervete Miftaraj, Ann‐Marie Svensson, et al.. (2013). Durability of oral hypoglycaemic agents in drug naive patients with type 2 diabetes : observational study from the Swedish National Diabetes Register (NDR). Diabetologia. 56. 1 indexed citations

12.

Cederholm, Jan, Björn Eliasson, Björn Zethelius, Katarina Eeg‐Olofsson, & Soffia Guðbjörnsdóttir. (2013). [Risk factors for cardiovascular disease. Results from the Swedish national diabetes register compared with international studies].. PubMed. 110(17-18). 882–5. 2 indexed citations

13.

Ekström, Nils, Jan Cederholm, Björn Zethelius, et al.. (2013). Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register. BMJ Open. 3(4). e002688–e002688. 15 indexed citations

14.

Ekström, Nils, Linus Schiöler, Ann‐Marie Svensson, et al.. (2012). Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open. 2(4). e001076–e001076. 174 indexed citations

15.

Zethelius, Björn, et al.. (2010). Risk prediction of cardiovascular disease in type 2 diabetes : a new risk equation from the Swedish NDR. Diabetologia. 53. 1 indexed citations

16.

Cederholm, Jan, Peter M. Nilsson, Björn Eliasson, et al.. (2009). [Connections between risk factors and complications in diabetes. A report after 13 years with the National Diabetes Registry (NDR)].. PubMed. 106(42). 2684–9. 3 indexed citations

17.

Zethelius, Björn, Lars Berglund, & Johan Sundström. (2008). Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. Journal of Vascular Surgery. 48(2). 500–500. 17 indexed citations

18.

Zethelius, Björn, et al.. (2008). The Interaction between Impaired Acute Insulin Response and Insulin Resistance Predict Type 2 Diabetes and Impairment of Fasting Glucose. Upsala Journal of Medical Sciences. 113(2). 117–130. 13 indexed citations

19.

Zethelius, Björn, Nina Johnston, & Per Venge. (2006). Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men. Circulation. 113(8). 1071–1078. 216 indexed citations

20.

Ingelsson, Erik, Johan Ärnlöv, Johan Sundström, et al.. (2005). Novel Metabolic Risk Factors for Heart Failure. Journal of the American College of Cardiology. 46(11). 2054–2060. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact